NEWS

Stryker’s Trevo™ Retriever becomes first and only device indicated for a...

Kalamazoo, Michigan, USA – Following the expanded indication in the United States by the Food and Drug Administration (FDA) in February, Stryker’s Trevo Retriever has received CE marking as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset, increasing the treatment window by 18 hours.

Unruptured intracranial aneurysm

Share your most interesting case and step on stage in Paris!

Stryker's commitment to stroke treatment rewarded!

Stryker’s commitment to stroke treatment rewarded

Like every year, in line with its dedication to complete stroke care, Stryker took part in the 2017 World Stroke Day by creating an exceptional campaign designed to raise awareness about the importance of recognizing the signs of a stroke and acting FAST!

What is it? What to do?

LINNC online new editor-in-chief: Rodrigo Rivera

Win your ticket for the LINNC Paris

LINNC US: download your certificate

Advancing neuroradiology and neurosurgery practice together